Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ARKG vs JETS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

JETS Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

JETS Overall Winner 6-Pillar Tally: ARKG 0 – 0 JETS (6 Tie) Matrix Metrics: ARKG 1 – 2 JETS

As of Nov 16, 2026, U.S. Global Jets ETF (JETS) is the stronger overall head-to-head candidate over ARK Genomic Revolution ETF (ARKG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ARKG carries a Unified Composite Score of 48.6/100 (HOLD) at $40.92 (N/M Forward P/E, N/A operating margin), whereas JETS carries 41.5/100 (SELL) at $28.98 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While ARKG currently prints a higher short-term Unified Composite Score (48.6/100 HOLD vs. JETS 41.5/100 SELL), JETS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ARKG vs JETS
ARKG Cboe BZX
ARK Genomic Revolution ETF
Institutional Equity
$40.92
-5.28% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 2.08β · 70% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 26.0 Fund 45.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 35
RSI-14: 35.2 · SMA20: $48.17 · SMA50: $49.46
JETS NYSE Arca Head-to-Head Winner
U.S. Global Jets ETF
Institutional Equity
$28.98
+0.5% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.51β · 42% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 20.0 Fund 34.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 54
RSI-14: 54.0 · SMA20: $27.99 · SMA50: $27.88

6-Pillar Scorecard Institutional Category Breakdown (ARKG 0 – 0 JETS)

Columns: Metric · ARKG · JETS
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 47.2% (38th %ile) 26.4% (32nd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ARKG (1) vs JETS (2)
Institutional Metric ARKG JETS Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
48% ($25–$59) 52% ($24–$34) Stronger Trend JETS
Beta / 30D Volatility
Risk Regime
2.08β · 70% Vol 1.51β · 42% Vol Lower Realized Risk JETS
Unified Institutional Score
Composite Signal
48.6 / 100 (HOLD) 41.5 / 100 (SELL) Higher Composite ARKG
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon JETS +24.51 pp
ARKG: -12.38% · JETS: +12.13%
3M Horizon JETS +0.9 pp
ARKG: -5.3% · JETS: -4.4%
6M Horizon ARKG +32.13 pp
ARKG: +45.57% · JETS: +13.44%
1Y Horizon ARKG +36.22 pp
ARKG: +51.33% · JETS: +15.11%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARKG vs JETS. Trailing 12-month operating profitability (ARKG N/A vs JETS N/A) and valuation multiples (ARKG N/M vs JETS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ARKG ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
JETS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ARKG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 47.2%
IV Percentile 38th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ARKG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
JETS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 26.4%
IV Percentile 32nd %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact JETS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ARKG Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
JETS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ARKG vs JETS Key Questions & Quantitative Answers

As of Nov 16, 2026, U.S. Global Jets ETF (JETS) is the stronger overall head-to-head candidate over ARK Genomic Revolution ETF (ARKG) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ARKG carries a Unified Composite Score of 48.6/100 (HOLD) at $40.92 (N/M Forward P/E, N/A operating margin), whereas JETS carries 41.5/100 (SELL) at $28.98 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ARKG currently prints a higher short-term Unified Composite Score (48.6/100 HOLD vs. JETS 41.5/100 SELL), JETS captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

ARKG and JETS split Growth & Scale metrics: ARKG posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with JETS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ARKG generates N/A in USD-normalized revenue versus N/A for JETS. In operating R&D and SG&A reinvestment, ARKG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for JETS.

ARKG and JETS trade at balanced relative valuation multiples. ARKG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas JETS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ARKG (N/A ROE) versus JETS (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ARKG carries 47.2% implied volatility (38th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.08β · 70% Vol realized risk). By comparison, JETS carries 26.4% implied volatility (32nd %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.51β · 42% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.